Psychodermatology: A brief review for clinicians

Psychiatria Danubina

Volumn 17, Issue 1-2, 2005, Pages 76-83

  Buljan, Danijel ^a   Buljan, Marija ^a   Šitum, Mirna ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Dermatology; Liaison psychiatry; Psychodermatology; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CORTICOSTEROID; DIURETIC AGENT; DOXEPIN; EMETIC AGENT; HALOPERIDOL; HYPNOTIC AGENT; ISOTRETINOIN; LAXATIVE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ACNE; ACUTE DISEASE; AKATHISIA; ALCOHOLISM; ANXIETY DISORDER; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; COGNITIVE THERAPY; CONSULTATION; DELUSION; DELUSIONAL DISORDER; DEPRESSION; DERMATITIS; DERMATOLOGY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG ERUPTION; DRY EYE; DYSTONIA; EATING DISORDER; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; HAIR LOSS; HUMAN; HYPOMANIA; LUPUS VULGARIS; MALINGERING; MANIA; MEDICAL SPECIALIST; MENTAL DISEASE; MENTAL STRESS; MUNCHAUSEN SYNDROME; OBSESSIVE COMPULSIVE DISORDER; PAIN; PARASITOSIS; PARKINSONISM; PHOTOSENSITIVITY; PHYSICIAN; PRESCRIPTION; PRURITUS; PSORIASIS; PSYCHIATRIST; PSYCHOLOGIST; PSYCHOMOTOR DISORDER; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SKIN DISEASE; SKIN MANIFESTATION; SUBSTANCE ABUSE; SUICIDE; TARDIVE DYSKINESIA; TENSION; TOXIC EPIDERMAL NECROLYSIS; TREATMENT PLANNING; TRICHOTILLOMANIA; URTICARIA; XEROSTOMIA;

DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; MENTAL DISORDERS; PATIENT CARE TEAM; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTROPIC DRUGS; RISK FACTORS; SKIN DISEASES; STRESS, PSYCHOLOGICAL;

EID: 23644446439     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998;197:230-4.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). American Psychiatric Association: Washington DC; 1994.
3. Asher R. Munchausen syndrome. Lancet 1951;1:339-41.
4. Attah Johnson FY, Mostaghimi H. Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 1995;34:244-8.
5. Bazire S. Psychotropic Drug Directory 2003/04. Fivepin publishing, 2003.
6. Bishop ER. Monosymptomatic hypochondrial syndromes in dermatology. J Am Acad Dermatol 1983;9:152-8.
7. Byrne A, Costello M, Greene E, Zibin T. Isotretinoin therapy and depression:evidence for an association. Ir J Psych Med 1998;15:58-60.
8. Champion RH, Burton A, Burns DA, Breathnach SM. In: Rook, Wilkinson, Ebling Textbook of Dermatology, Vol 4, Sixth Ed
9. Conde-Salazar L, Gomez J, Meza B. Artefactual irritant dermatits. Contact Dermatitis 1993;28:246-7.
10. Consoli S. Dermatitis artefacta: a general review. Eur J Dermatol, 1995;5:5-11.
11. Coterill JA. Dermatologic non -disease. Dermatol Clin 1996:14:439-45.
12. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997;137:246-50.
13. Editorial. Selective serotonin reuptake inhibitors in obsessive/compulsive disorder. Drugs Ther Bull 1995;33:47-48.
14. Gorman WF, Burket BA. Crossing the border from Munchausen to malingering. J Fla Med Assoc 1988;75:147-50.
15. Gupta AK, Knowles SR, Gupta MA, Jaunkains R, Shear NH. Lithium therapy associated with hidradenitis suppurativa: case report and review of the dermatologic side effects of lithium. J Am Dermatol 1995;32:382-96.
16. Haman K. Onychotillomania treated with pimozide. Acta Derm Venereol (Stockh) 1982;62:364-6.
17. Harris BA, Sherertz EF, Flowers FP. Improvement of chronic neurotic excoriations with doxepin therapy. Int J Dermatol 1987; 26:541-3.
18. Harris BA, Sherertz EF, Flowers FP. Improvement of chronic neurotic excoriations with oral doxepin therapy. Int J Dermatol 1987;26:541-3.
19. Hatch ML, Paradis C, Friedman S, Popkin M, Shalita R. Obsessive-compulsive disorder inpatients with chronic pruritic conditions: case studies and discussion. J Am Acad Dermatol 1992;26:549-55.
20. Herpertz S. Self-injurious behaviour. Psycopathological and nosological characteristics in subtypes of self-injurers. Acta Psychiatr Scand 1995;91:57-68.
21. Iyer S, Wqshenik K, Shupack J. Can psychological stress affect psoriasis? Possible mechanisms. J Clin Dermatol 1988; 1(5):21-8.
22. Jacobs DG, Deutch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001;45:S168-S175.
23. Kadri N, Moussaoui D. Dermatology and psychiatry. WPA Bulletin on Depression Vol. 7-No 26, 2003.
24. Klein JF. Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician 1992;46:1469-74.
25. Koblenzer CS. Cutaneous manifestations of psychiatric diseases that commonly present to the dermatologist-diagnostic and treatment. Int J Psychiary 1992;22:47-63.
26. Koblenzer CS. Dermatitis artefacta: Clinical features and approaches to treatment. Am J Clin Dermatol 2000;1:47-55.
27. Koblenzer CS. Psychiatric syndromes of interest to dermatologists. Int J Dermatol 1993;32:82-8.
28. Koblenzer CS. Psychocutaneous disease. Orlando: Grune & Stratton, 1987:77-8, 117.
29. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983;119:501-12.
30. Koo J, Gamba C. Psychopharmacology for dermatological patients. Dermatol Clin 1996;14:509-25.
31. Koo J, Lebwohl A. Psychodermatology: The Mind and Skin Connection. Am Family Phys 2001;11:1873-8.
32. Koo J. Skin disorders. In: Kaplan HI, Saduck BJ, eds. Comprehensive textbook of psychiatry. 6th ed Baltimore: Williams & Wilkins, 1995.
33. Koo JY, Pham CT. Psychodermatology. Arc Dermatol 1992;128:381-388.
34. Koo JY. Psychodermatology: a practical manual for clinitians. Cur Prob Dermatol 1995;204-32.
35. Koo JYM. Psychodermatology. Current Concepts. Upjohn, 1989:1-45.
36. Koo YM. The use of psychotropic medications in clinical dermatology. Dermatol Clin 1992; 10: 641-5.
37. Lachapellle JM, Pierard GE. Traumatic alopecia in tichotillomania; a pathogenic interpretation of histologic lesions in the pilosebaceus unit. J Cutan Pathol 1997; 4: 51-67.
38. Lyell A. Cutaneous artefactual disease. J Am Acad Dermatol 1979;1:391-407.
39. Lyell A. Delusions of parasitosis. Br J Dermatol 1983;108:485-99.
40. Meadow SR. Munchausen syndrome by proxy. Arch Dis Child 1982;57:92-8.
41. Munro A. Delusional parasitosis: a form of monosymptomatic hypochondrial psychosis. Semin Dermato 1983;2:197-202.
42. Paduart O, Heenen M. Dermatology and psychotropic drugs. Ann Dermatol Venereol, 1997;124:878-81.
43. Panconesi E, Hautmann G. Psychophysiology of stress sin Dermatology: the psychologic pattern of psychosomatics. Dermatologic Clinics 1996;3:399-421.
44. Phillips KA, Dufresne RG, Wilkel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000;43:229-233.
45. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983-91.
46. Picardi A., Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001; 81:410-4.
47. Prosperi A, Micallef J, Blin O. The use of psychotropic drug sin dermatology. Ann Dermatol Venereol 2002;129:446-9.
48. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalised pruritus. Br J Dermatol 1990;123:769-74.
49. Stahl SM. Essential Psychopharmacology, Neuroscientific Basis and Practical Aplications. Cambrige: Cambrige University Press; 2000.
50. Stein DJ, Mullen L, Islam MN, Cohen L, DeCaria CM, Hollander E. Compulsive and Impulsive symptomatology in trichotillomania. Psychopathology 1995; 28:208-13.
51. Szaz T. Malingering. Diagnosis or social condemnation. Arc Neurol Psychiatry 1967;195:432-43.
52. Van Moffaert M, Vermander F, Kint A. Dermatitis artefacta. Int J Dermatol 1985; 24:236-8.
53. Van Moffaert M. Psychodermatology: an overview. Psychother Psychosom 1992;58:125-36.
54. Veale D. Friday the 13th and obsessive compulsive disorder: better understanding has brought some success in treatment. Br Med J 1995;311:963-4.
55. Wada K. Recurrent cases of corticosteroid-induced mood disorder: clinical caracteristics and treatment.J Clin Psychiatry 2000. In press
56. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attendees at a dermatology clinic. Br J Psychiatry 1998;155:686-91.
57. Wooduruff PW, Higgins EM, Du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatolog-psychiatry clinic. Gen Hosp Psychiatry 1997;19:29-35.
58. World Health Organisation. Classification of Mental and Behavioral Disorders 10th ed. World Helth Organisation and Longman Group Limited: Geneve; 1994.